Insider Trading activities of Dexcom Inc insiders. , Part 5

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dexcom Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dexcom Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Dexcom Inc since 2005. The reporting company's ticker symbol is DXCM. The reporting company's CIK number is 1093557.
The total value of stock buying since 2005 is $4,721,044.
The total value of stock sales since 2005 is $539,675,318.
The total value of stock option exercises since 2005 is $34,498,305.



Table 2. Detailed insider stock purchases, sales, and option exercises of Dexcom Inc insiders (DXCM) , Part 5
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-08-14 Gregg Terrance H (CEO) Option Ex 25,000 7.90 197,500
2014-08-13 Gregg Terrance H (CEO) Sale 38,607 43.79 1,690,523
2014-08-13 Gregg Terrance H (CEO) Option Ex 38,607 6.33 244,382
2014-08-12 Lister John (Sr. VP, General Counsel) Sale 3,353 43.68 146,455
2014-08-12 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-08-12 Gregg Terrance H (CEO) Sale 17,500 43.09 754,057
2014-08-12 Gregg Terrance H (CEO) Option Ex 17,500 8.95 156,625
2014-08-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 44.24 442,370
2014-08-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 8.94 89,400
2014-08-11 Sayer Kevin R (President & COO) Sale 20,000 43.83 876,500
2014-08-08 Valdes Jorge A (CTO) Sale 16,000 43.56 697,008
2014-08-08 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2014-07-25 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 38.19 381,860
2014-07-25 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 8.94 89,400
2014-07-23 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 4,000 38.16 152,656
2014-07-23 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 4,000 6.03 24,120
2014-07-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 38.28 535,990
2014-07-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.63 106,820
2014-07-18 Roper Jess (VP, CFO) Sale 8,000 36.01 288,072
2014-07-18 Roper Jess (VP, CFO) Option Ex 8,000 7.79 62,320
2014-07-15 Gregg Terrance H (CEO) Sale 35,000 36.66 1,283,135
2014-07-15 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-07-14 Lister John (Sr. VP, General Counsel) Sale 3,500 36.59 128,075
2014-07-14 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-07-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 35.94 359,350
2014-07-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 8.94 89,400
2014-07-08 Valdes Jorge A (CTO) Sale 16,000 36.66 586,512
2014-07-08 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2014-07-02 Skyler Jay S (Director) Sale 12,200 40.09 489,110
2014-07-01 Skyler Jay S (Director) Sale 17,800 40.02 712,284
2014-06-25 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 40.60 405,980
2014-06-25 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 8.94 89,400
2014-06-23 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 4,000 40.98 163,924
2014-06-23 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 4,000 6.03 24,120
2014-06-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 41.02 574,238
2014-06-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.44 104,160
2014-06-20 Skyler Jay S (Director) Sale 30,000 40.00 1,200,000
2014-06-19 Skyler Jay S (Director) Sale 30,000 40.00 1,200,000
2014-06-18 Roper Jess (VP, CFO) Sale 8,000 39.17 313,336
2014-06-18 Roper Jess (VP, CFO) Option Ex 8,000 7.52 60,160
2014-06-16 Gregg Terrance H (CEO) Sale 35,000 37.23 1,303,120
2014-06-16 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-06-12 Lister John (Sr. VP, General Counsel) Sale 3,500 36.13 126,455
2014-06-12 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-06-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 36.63 366,310
2014-06-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 8.94 89,400
2014-06-09 Valdes Jorge A (CTO) Sale 16,000 36.68 586,864
2014-06-09 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2014-06-05 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 4,000 35.59 142,356
2014-06-05 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 4,000 6.03 24,120
2014-05-31 Topol Eric (Director) Sale 12,207 .00 12
2014-05-31 Topol Eric (Director) Option Ex 12,207 .00 12
2014-05-27 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 33.86 338,640
2014-05-27 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.25 72,500
2014-05-23 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 18,750 32.89 616,612
2014-05-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 32.76 458,626
2014-05-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.25 101,500
2014-05-19 Roper Jess (VP, CFO) Sale 8,000 32.20 257,576
2014-05-19 Roper Jess (VP, CFO) Option Ex 8,000 4.54 36,344
2014-05-15 Gregg Terrance H (CEO) Sale 35,000 31.15 1,090,145
2014-05-15 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-05-12 Lister John (Sr. VP, General Counsel) Sale 3,500 31.52 110,320
2014-05-12 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-05-12 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 31.75 317,500
2014-05-12 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.25 72,500
2014-05-08 Kahn Barbara (Director) Sale 7,500 30.11 225,855
2014-05-08 Valdes Jorge A (CTO) Sale 16,000 29.83 477,328
2014-05-08 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2014-04-25 Moy Jeffrey (SVP, Operations) Option Ex 5,097 8.49 43,299
2014-04-25 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 34.35 343,459
2014-04-25 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.25 72,500
2014-04-23 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 4,000 35.92 143,688
2014-04-23 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 4,000 6.03 24,120
2014-04-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 35.91 502,670
2014-04-23 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.25 101,500
2014-04-21 Roper Jess (VP, CFO) Sale 8,000 36.18 289,472
2014-04-21 Roper Jess (VP, CFO) Option Ex 8,000 3.19 25,520
2014-04-15 Gregg Terrance H (CEO) Sale 35,000 34.09 1,193,010
2014-04-15 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-04-14 Lister John (Sr. VP, General Counsel) Sale 2,884 35.86 103,420
2014-04-14 Lister John (Sr. VP, General Counsel) Option Ex 1,750 4.58 8,015
2014-04-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 35.36 353,560
2014-04-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.25 72,500
2014-04-08 Valdes Jorge A (CTO) Sale 16,000 35.99 575,904
2014-04-08 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2014-04-07 Moy Jeffrey (SVP, Operations) Option Ex 6,464 4.76 30,768
2014-04-01 Skyler Jay S (Director) Sale 30,000 41.29 1,238,790
2014-03-27 Moy Jeffrey (SVP, Operations) Option Ex 15,000 6.33 94,950
2014-03-26 Skyler Jay S (Director) Sale 30,000 43.05 1,291,470
2014-03-25 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 43.00 429,960
2014-03-25 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.25 72,500
2014-03-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 42.91 600,810
2014-03-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 7.25 101,500
2014-03-18 Roper Jess (VP, CFO) Sale 8,000 46.00 368,000
2014-03-18 Roper Jess (VP, CFO) Option Ex 8,000 3.19 25,520
2014-03-18 Valdes Jorge A (CTO) Option Ex 27,100 13.45 364,495
2014-03-17 Gregg Terrance H (CEO) Sale 35,000 45.12 1,579,200
2014-03-17 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-03-13 Gregg Terrance H (CEO) Sale 10,000 45.09 450,900
2014-03-13 Gregg Terrance H (CEO) Option Ex 10,000 8.95 89,500
2014-03-13 Lord Jonathan T Md (Director) Sale 36,000 45.05 1,621,800
2014-03-13 Lord Jonathan T Md (Director) Option Ex 36,000 7.78 280,080
2014-03-12 Lister John (General Counsel, VP of HR) Sale 9,158 45.13 413,337
2014-03-12 Lister John (General Counsel, VP of HR) Option Ex 1,750 4.58 8,015
2014-03-12 Gregg Terrance H (CEO) Sale 20,000 45.38 907,580
2014-03-12 Gregg Terrance H (CEO) Option Ex 20,000 8.95 179,000
2014-03-11 Doubleday Richard (Sr. VP. Worldwide Sales) Sale 50,000 46.42 2,321,250
2014-03-11 Doubleday Richard (Sr. VP. Worldwide Sales) Option Ex 50,000 6.03 301,500
2014-03-11 Valdes Jorge A (CTO) Sale 23,437 46.18 1,082,320
2014-03-11 Valdes Jorge A (CTO) Option Ex 23,437 13.45 315,227
2014-03-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 45.93 459,270
2014-03-11 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.25 72,500
2014-03-11 Gregg Terrance H (CEO) Sale 10,000 45.75 457,500
2014-03-11 Gregg Terrance H (CEO) Option Ex 10,000 8.95 89,500
2014-03-10 Valdes Jorge A (CTO) Sale 16,000 46.57 745,120
2014-03-10 Valdes Jorge A (CTO) Option Ex 16,000 3.19 51,040
2014-03-06 Gregg Terrance H (CEO) Sale 20,500 47.77 979,182
2014-03-06 Gregg Terrance H (CEO) Option Ex 20,500 7.90 161,950
2014-03-05 Moy Jeffrey (SVP, Operations) Sale 5,000 47.50 237,500
2014-03-05 Moy Jeffrey (SVP, Operations) Option Ex 5,000 6.33 31,650
2014-03-05 Gregg Terrance H (CEO) Sale 66,890 47.25 3,160,619
2014-03-05 Gregg Terrance H (CEO) Option Ex 66,890 5.78 386,824
2014-03-04 Moy Jeffrey (SVP, Operations) Sale 5,000 47.10 235,500
2014-03-04 Moy Jeffrey (SVP, Operations) Option Ex 5,000 6.33 31,650
2014-03-04 Gregg Terrance H (CEO) Sale 45,000 46.79 2,105,640
2014-03-04 Gregg Terrance H (CEO) Option Ex 45,000 13.93 626,625
2014-03-03 Gregg Terrance H (CEO) Sale 25,000 44.65 1,116,300
2014-03-03 Gregg Terrance H (CEO) Option Ex 25,000 8.59 214,750
2014-02-28 Moy Jeffrey (SVP, Operations) Sale 2,500 46.45 116,125
2014-02-28 Moy Jeffrey (SVP, Operations) Option Ex 2,500 6.33 15,825
2014-02-28 Gregg Terrance H (CEO) Sale 15,000 45.08 676,140
2014-02-28 Gregg Terrance H (CEO) Option Ex 15,000 8.95 134,250
2014-02-26 Moy Jeffrey (SVP, Operations) Sale 11,250 45.72 514,394
2014-02-26 Moy Jeffrey (SVP, Operations) Option Ex 11,250 4.76 53,550
2014-02-26 Roper Jess (VP, CFO) Sale 25,000 45.20 1,130,050
2014-02-26 Roper Jess (VP, CFO) Option Ex 25,000 7.63 190,750
2014-02-25 Topol Eric (Director) Sale 50,000 45.17 2,258,550
2014-02-25 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 19,368 45.16 874,678
2014-02-25 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 19,368 20.65 399,949
2014-02-25 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 44.97 449,690
2014-02-25 Balo Andrew K (SVP, Regulatory and Clinical) Option Ex 10,000 7.25 72,500
2014-02-25 Lord Jonathan T Md (Director) Sale 64,807 45.15 2,926,100
2014-02-25 Lord Jonathan T Md (Director) Option Ex 64,807 4.58 296,816
2014-02-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Sale 14,000 44.60 624,442
2014-02-24 Pacelli Steven Robert (EVP, Strategy & Corp. Dev.) Option Ex 14,000 5.22 73,080
2014-02-18 Roper Jess (VP, CFO) Sale 8,000 43.57 348,552
2014-02-18 Roper Jess (VP, CFO) Option Ex 8,000 3.19 25,520
2014-02-18 Gregg Terrance H (CEO) Sale 35,000 43.73 1,530,655
2014-02-18 Gregg Terrance H (CEO) Option Ex 25,000 6.85 171,250
2014-02-11 Balo Andrew K (SVP, Regulatory and Clinical) Sale 10,000 39.50 394,970

Insider trading activities including stock purchases, stock sales, and option exercises of DXCM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dexcom Inc (symbol DXCM, CIK number 1093557) see the Securities and Exchange Commission (SEC) website.